A time-resolved fluoroimmunoassay for 18-oxocortisol and 18-hydroxycortisol: Development of a monoclonal antibody to 18-oxocortisol

Journal of Steroid Biochemistry and Molecular Biology

Volumn 82, Issue 1, 2002, Pages 83-88

  Morra di Cella, Stefania ^a   Veglio, Franco ^b   Mulatero, Paolo ^c   Christensen, Valerie ^c   Aycock, Keli ^b   Zhu, Zheng ^b   Gomez Sanchez, Elise P ^b   Gomez Sanchez, Celso E ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

18 Hydroxycortisol; 18 Oxocortisol; TR FIA technique

Indexed keywords

18 HYDROXYHYDROCORTISONE; 18 OXOHYDROCORTISONE; AVIDIN; EUROPIUM; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; STREPTAVIDIN;

ACCURACY; ADRENAL DISEASE; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROIMMUNOASSAY; HORMONE DETERMINATION; HUMAN; HYPERALDOSTERONISM; INTERMETHOD COMPARISON; MALE; STEROID EXCRETION; STEROID URINE LEVEL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BIOLOGICAL MARKERS; FEMALE; FLUOROIMMUNOASSAY; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM; MALE; MICE;

EID: 0036757839     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(02)00142-5     Document Type: Article

References (39)

1. Chu M.D., Ulick S. Isolation and identification of 18-hydroxycortisol from the urine of patients with primary aldosteronism. J. Biol. Chem. 258:1982;2218-2224.
2. Ulick S., Chu M.D. Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension. Clin. Exp. Hypertens. A4:1982;1771-1777.
3. Ulick S., Chu M.D., Land M. Biosynthesis of 18-oxocortisol by aldosterone-producing adrenal tissue. J. Biol. Chem. 258:1983;5498-5502.
4. Ulick S., Chu M.D. Isolation and identification of an endogenous metabolite of 18-oxocortisol from human urine. J. Steroid Biochem. 28:1987;89-94.
5. Gomez-Sanchez E.P., Gomez-Sanchez C.E., Smith J.S., Ferris M.W., Foecking M.F. Receptor binding and biological activity of 18-hydroxycortisol. Endocrinology. 115:1984;462-466.
6. Gomez-Sanchez C.E., Gomez-Sanchez E.P., Smith J.S., Ferris M.W., Foecking M.F. Receptor binding and biological activity of 18-oxocortisol. Endocrinology. 116:1985;6-10.
7. Ulick S., Land M., Chu M.D. 18-Oxocortisol, a naturally occurring mineralcorticoid agonist. Endocrinology. 113:1983;2320-2322.
8. Hall C.E., Gomez-Sanchez C.E., Hungerford S. Hypertensive potency of 18-oxocortisol in the rat. Hypertension. 8:1986;317-322.
9. Spence C.D., Coghlan J.P., Denton A.D., Gomez-Sanchez C.E., Mills E.H., Withworth J.A., Scoggins B.A. Blood pressure and metabolic effects of 18-oxocortisol in sheep. J. Steroid Biochem. 28:1987;441-444.
10. Gomez-Sanchez C.E., Upcavage R.J., Zager P.G., Foecking M.F., Holland O.B., Ganguly A. Urinary 18-hydroxycortisol and its relationship to the excretion of other adrenal steroids. J. Clin. Endocrinol. Metab. 65:1987;310-314.
11. Hamlet S.M., Gordon R.D., Gomez-Sanchez C.E., Tunny T.J., Klemm S.A. Adrenal transitional zone steroids, 18-oxo and 18-hydroxycortisol, useful in the diagnosis of primary aldosteronism are ACTH-dependent. Clin. Exp. Pharmacol. Physiol. 15:1988;317-322.
12. Gomez-Sanchez C.E., Montgomery M., Ganguly A., Holland O.B., Gomez-Sanchez E.P., Grim C.E., Weinberger M.H. Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism. J. Clin. Endocrinol. Metab. 59:1984;1022-1024.
13. Gomez-Sanchez C.E., Zager P.G., Foecking M.F., Holland O.B., Ganguly A. 18-Oxocortisol: effect of dexamethasone, ACTH and sodium depletion. J. Steroid Biochem. 32:1989;409-412.
14. Sutherland D.J.A., Ruse J.L., Laidlaw J.C. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can. Med. Assoc. J. 95:1966;1109-1119.
15. New M.I., Siegal E.J., Peterson R.E. Dexamethasone-suppressible hyperaldosteronism. J. Clin. Endocrinol. Metab. 37:1973;93-100.
16. Ulick S., Chan C.K., Gill J.R., Gutkin M., Letcher L., Mantero F., New M.I. Defective fasciculata zone function as the mechanism of Glucocorticoid-remediable aldosteronism. J. Clin. Endocrinol. Metab. 71:1990;1151-1157.
17. Gill J.R., Bartter F.C. Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism. J. Clin. Endocrinol. Metab. 53:1981;331-337.
18. Gomez-Sanchez C.E., Gill J.J.R., Ganguly A., Gordon R.D. Glucocorticoid-suppressible aldosteronism: a disorder of the adrenal transitional zone. J. Clin. Endocrinol. Metab. 67:1988;444-448.
19. Lifton R.P., Dluhy R.G., Powers M., Rich G.M., Gutkin M., Fallo F., Gill J.R., Feld L., Ganguly A., Laidlaw J.C., Murnaghan D.J., Kauffman C., Stockigt J., Ulick l., Lalouel J.-M. Hereditary hypertension caused by chimeric gene duplication and ectopic expression of aldosterone synthase. Nat. Genet. 2:1992;66-74.
20. Pascoe L., Curnow K.M., Slutsker L., Connell J.M.C., Speiser P.W., New M.I., White P.C. Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc. Natl. Acad. Sci. U.S.A. 89:1992;8327-8331.
21. Jonsson J.R., Klemm S.A., Tunny T.J., Stowasser M., Gordon R.D. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem. Biophys. Res. Commun. 207:1995;565-571.
22. Mulatero P., Veglio F., Pilon C., Rabbia F., Zocchi C., Limone P., Boscaro M., Sonino N., Fallo F. Diagnosis of glucocorticoid-remediable aldosteronism: aldosterone response to dexamethasone and long-polymerase chain reaction for chimeric gene. J. Clin. Endocrinol. Metab. 83:1998;2573-2575.
23. Ulick S., Blumenfeld J.D., Atlas S.A., Wang J.Z., Vaughan E.D. The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism. J. Clin. Endocrinol. Metab. 76:1993;873-878.
24. Carroll J., Dluhy R., Fallo F., Pistorello M., Bradwin G., Gomez-Sanchez C.E., Mortensen R. Aldosterone-producing adenomas (APA) do not contain glucocorticoid-remediable aldosteronism (GRA) chimeric gene duplications. J. Clin. Endocrinol. Metab. 81:1996;4310-4312.
25. Pilon C., Mulatero P., Barzon L., Veglio F., Garrone C., Boscaro M., Sonino N., Fallo F. Mutations in CYP11B1 gene converting 11β-hydroxylase into an aldosterone-producing enzyme are not present in aldosterone-producing adenomas. J. Clin. Endocrinol. Metab. 84:1999;4228-4231.
26. Yamakita N., Mune T., Morita H., Yoshida H., Yasuda K., Miura K., Gomez-Sanchez C.E. Plasma 18-oxocortisol levels in the patients with adrenocortical disorders. Clin. Endocrinol. 40:1994;583-587.
27. Yamakita N., Gomez-Sanchez C.E., Mune T., Morita H., Yoshida H., Miyazaki S., Yasuda K. Simultaneous measurement of plasma 18-oxocortisol and 18-hydroxycortisol levels in normal man. Eur. J. Endocrinol. 131:1994;74-79.
28. Gomez-Sanchez C.E., Leon L.M., Gomez-Sanchez E.P. Biotin-hydrazide derivatives for the development of steroid enzyme-linked immunoassays. J. Steroid Biochem. Mol. Biol. 43:1992;523-528.
29. 125I J. Steroid Biochem. Mol. Biol. 72:2000;55-60.
30. Boudi A., Giton F., Galons H., Eulry B., Villette J.M., Soliman H., Boudou P., Fiet J. Development of a plasma 17α-hydroxyprogesterone time-resolved fluorescence immunoassay involving a new biotinylated tracer. Steroids. 65:2000;103-108.
31. Gomez-Sanchez C.E., Kirk D.N., Farrant R.D., Milewich L. 18-Substituted steroids: synthesis of 18-hydroxycortisol (11β,17α,18,21-tetrahydroxy-4-pregnene-3,20-dione) and 18-hydroxycortisone(17α,18,21-trihydroxy-4-pregrene-3,11-20-trione). J. Steroid Biochem. 22:1985;141-145.
32. Davis J.M. A single-step technique for selecting and cloning hybridomas for monoclonal antibody production. Methods Enzymol. 121:1986;322-327.
33. Degan P., Montesano R., Abbondandolo A., Montagnoli G. Time-resolved fluoroimmunoassay of 7-methil-2′-deoxyguanosine imidazole (ring open). J. Immunol. Methods. 133:1990;119-125.
34. Mosso L., Gomez-Sanchez C.E., Foecking M.F., Fardella C. Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives. Hypertension. 38:2001;688-691.
35. Corrie J.E.T., Edwards C.R.W., Budd P.S. A radioimmunoassay for 18-hydroxycortisol in plasma and urine. Clin. Chem. 31:1985;849-852.
36. Gomez-Sanchez C.E., Gomez-Sanchez E.P., Holland O.B. Role of 18-hydroxylated cortisols in hypertension. J. Steroid Biochem. 27:1987;971-975.
37. Taymans S., Pack S., Pak E., Torpy D., Zhuang Z., Stratakis C. Human CYP11B2 (aldosterone synthase) maps to chromosome 8q24.3. J. Clin. Endocrinol. Metab. 83:1998;1033-1036.
38. Mulatero P., Curnow K.M., Aupetit-Faisant B., Foeking M., Gomez-Sanchez C.E., Veglio F., Jeunemaitre X., Corvol P., Pascoe L. Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. J. Clin. Endocrinol. Metab. 83:1998;3996-4001.
39. Pascoe L., Jeunemaitre X., Lebrethon M.C., Curnow K.M., Gomez-Sanchez C.E., Gasc J.M., Saez J.M., Corvol P. Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J. Clin. Invest. 96:1995;2236-2246.